UnknownNCT05980143

Metacognitive Therapy for Common Mental Health Problems in Autistic CYP: A Case Series

This study has public registry information. It focuses on depression and currently lists study information in the United Kingdom.

Depression, AnxietyOtherFrom 11 Years to 16 Years

Need help deciding?

Ask HopeStage to review this study with me

Study reference: NCT05980143. HopeStage can help you review the study, but cannot decide medical eligibility.

In plain English

Key information made simple

This study is looking at offer five autistic CYP MCT for people with Anxiety or Depression. Participants take part in the program and complete follow-up questionnaires or assessments. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

What to expect

Your next step

The official record suggests in-person participation through a university, with sites including Manchester University NHS Foundation Trust and Pennine Care NHS Foundation Trust in Manchester. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually being able to understand the study and consent and matching the main diagnosis, while common reasons not to take part include safety concerns that need urgent care first and other factors that could make participation unsuitable. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.

Before joining

Questions to ask before joining

What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?

Study clarity

Things to check before joining

Study start dateStarted: October 25, 2023

Time commitment: multiple visits or assessments
Study phase: Not available
Enrollment: Not available
Recruitment status: Unknown
Sponsor: University of Manchester
Sponsor type: University
Main activity: digital app or tool
Intervention: Not available
Source: Official registry link

Want help reviewing this study?

Public study data

Key study information

Official title: Metacognitive Therapy for Common Mental Health Problems in Autistic CYP: A Case Series
Condition: Depression, Anxiety
Study status: Unknown
Sponsor / lead affiliation: University of Manchester
Location / country: United Kingdom
Registry: ClinicalTrials.gov
External trial ID: NCT05980143

Why this study may matter

This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.

In practice

For you

Taking part may help improve understanding of your condition.

It requires regular follow-up, often through questionnaires or interviews.

Requires travel, with in-person participation in United Kingdom.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Official title: Metacognitive Therapy for Common Mental Health Problems in Autistic CYP: A Case Series
Source: ClinicalTrials.gov
Official registry link: Open official registry
External trial ID: NCT05980143

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is Metacognitive Therapy for Common Mental Health Problems in Autistic CYP: A Case Series?

This study is exploring digital app or tool for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.

Who is behind this study, and what type of sponsor is it?

This study is sponsored by University of Manchester. Based on the sponsor name or official registry information, it appears to be a university. You should verify the details in the official registry record.

What does participation involve, what phase is it, and what should I ask about safety?

This study may involve digital app or tool, study visits, and assessments. The time commitment is multiple visits or assessments. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.

Where can I verify the study details?

Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me